pre-IPO PHARMA

virion-therapeutics PRESS RELEASE ARCHIVE

Jun 21, 2023

Virion Therapeutics Presents VRON-0200 Preclinical Data Showing Direct Correlations Between Intrahepatic CD8+ T cells and Hepatitis B Virus Declines (HBV) at EASL 2023


Mar 6, 2023

Virion Therapeutics Presents Promising Preclinical Cancer Data When Using a Novel Genetically Encoded Checkpoint Modifier-Based Immunotherapy


Feb 22, 2023

Center for Breakthrough Medicines and Virion Therapeutics Announce Strategic Partnership to Manufacture Virion's Proprietary CD8+ T cell-based Clinical Development Programs for Infectious Diseases and Cancers


Nov 17, 2020

Virion Therapeutics Wins Prestigious 'Most Valued Company' at Keiretsu Forum Investor Capital Expo


Oct 1, 2018

Virion Therapeutics, LLC Announces its Inaugural Board of Directors and Scientific Advisory Board Members



Sep 26, 2018

Virion Therapeutics, LLC Raises $5 Million to Develop Checkpoint Inhibitor Powered Vaccine Therapies for Treatment of Virally Induced Infectious Diseases and Cancers


Google Analytics Alternative